498 related articles for article (PubMed ID: 19743648)
1. Jay Crowley the FDA's perspective on the unique device identification system.
Crowley J
Healthc Financ Manage; 2009 Sep; 63(9):48-51. PubMed ID: 19743648
[No Abstract] [Full Text] [Related]
2. Jane Pleasants a provider's perspective on the unique device identification system.
Pleasants J
Healthc Financ Manage; 2009 Sep; 63(9):52-3. PubMed ID: 19743649
[No Abstract] [Full Text] [Related]
3. ECRI comments on FDA's reuse plan.
Healthc Hazard Manage Monit; 2000 Jun; 13(10):4-5. PubMed ID: 11125912
[No Abstract] [Full Text] [Related]
4. Using the FDA's Device Experience Network.
Collins JL
Oncol Nurs Forum; 1992 Apr; 19(3):524. PubMed ID: 1594477
[No Abstract] [Full Text] [Related]
5. FDA's medical device standards policy.
Stimson RA
J Parenter Sci Technol; 1981; 35(2):60-2. PubMed ID: 7229834
[No Abstract] [Full Text] [Related]
6. Process of elimination. Know what to ask when choosing a third-party reprocessor.
Furman PJ
Mater Manag Health Care; 2002 Mar; 11(3):22-4. PubMed ID: 11925673
[No Abstract] [Full Text] [Related]
7. The industry's take on data standards.
Nachtmann H; Pohl E
Mater Manag Health Care; 2009 Mar; 18(3):12-6. PubMed ID: 19385273
[No Abstract] [Full Text] [Related]
8. Disinfection guidelines: the great debate.
Souhrada L
Mater Manag Health Care; 1997 Mar; 6(3):40, 42, 44. PubMed ID: 10165578
[No Abstract] [Full Text] [Related]
9. Is FDA's medical device evaluation process overly complaisant to industry?
Margolis RE
Healthspan; 1992; 9(7):19-20. PubMed ID: 10121440
[No Abstract] [Full Text] [Related]
10. Misuse of the FDA's humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder.
Fins JJ; Mayberg HS; Nuttin B; Kubu CS; Galert T; Sturm V; Stoppenbrink K; Merkel R; Schlaepfer TE
Health Aff (Millwood); 2011 Feb; 30(2):302-11. PubMed ID: 21289352
[TBL] [Abstract][Full Text] [Related]
11. FDA's Quality System Inspection Technique in Ireland.
Higgins S
Med Device Technol; 2001; 12(1):40-1. PubMed ID: 11317865
[No Abstract] [Full Text] [Related]
12. The FDA's response to the GAO's report: new effort to tighten the pre-market review process for select Class III medical devices.
Kim JH; Smith J; Greis J; Werling K
Health Care Law Mon; 2009 May; 2009(5):2-8. PubMed ID: 19449776
[No Abstract] [Full Text] [Related]
13. FDA issues Unique Device Identification final rule.
Mathias JM
OR Manager; 2013 Nov; 29(11):5, 26. PubMed ID: 24298669
[No Abstract] [Full Text] [Related]
14. FDA's developing standards policy.
Link DM
Med Instrum; 1979; 13(4):196-7. PubMed ID: 470656
[No Abstract] [Full Text] [Related]
15. Solve a unique challenge. Product identifiers get industrywide attention.
DiConsiglio J
Mater Manag Health Care; 2007 Sep; 16(9):24-8, 30. PubMed ID: 17955920
[No Abstract] [Full Text] [Related]
16. The FDA's policy on the regulation of computerized medical devices.
Furfine CS
MD Comput; 1992; 9(2):97-100. PubMed ID: 1573995
[No Abstract] [Full Text] [Related]
17. ECRI to clinical engineering departments: "heads up! ... FDA's potential regulation of servicers, remarketers, and refurbishers could affect you".
Health Devices; 1998 Aug; 27(8):276. PubMed ID: 9743899
[No Abstract] [Full Text] [Related]
18. Problems in sterile devices. The FDA's view of the problem.
Butts HE
Hosp Manage; 1971 Apr; 111(4):37. PubMed ID: 16329343
[No Abstract] [Full Text] [Related]
19. Voluntary consensus standards and the FDA's regulatory program.
Gardner S
Med Instrum; 1979; 13(4):239-42. PubMed ID: 470665
[No Abstract] [Full Text] [Related]
20. FDA's focus on consensus standards: the vision, the heartbreak, the hope.
Altman MR; Marlowe DE
Stand News; 1999 May; 27(5):24-5. PubMed ID: 10558422
[No Abstract] [Full Text] [Related]
[Next] [New Search]
